Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics
2011

How Factor XIIIA Affects Bone Cell Function

publication 10 minutes Evidence: moderate

Author Information

Author(s): Al-Jallad Hadil F., Myneni Vamsee D., Piercy-Kotb Sarah A., Chabot Nicolas, Mulani Amina, Keillor Jeffrey W., Kaartinen Mari T.

Primary Institution: McGill University

Hypothesis

Factor XIIIA regulates osteoblast differentiation and matrix deposition through its effects on microtubule dynamics.

Conclusion

Inhibition of Factor XIIIA disrupts microtubule organization and reduces collagen and fibronectin secretion in osteoblasts.

Supporting Evidence

  • NC9 treatment reduced collagen deposition to 20% of control levels.
  • Factor XIIIA was found to be associated with microtubules at the plasma membrane.
  • Inhibition of Factor XIIIA led to a disorganized microtubule network.
  • Secretory vesicle delivery to the plasma membrane was decreased in NC9-treated cells.
  • FXIIIA inhibition resulted in lower levels of synaptotagmin VII on the plasma membrane.

Takeaway

Factor XIIIA helps bone cells work properly by keeping their internal structure organized, which is important for making bone.

Methodology

The study used an irreversible transglutaminase inhibitor (NC9) to block Factor XIIIA activity in osteoblast cultures and analyzed the effects on collagen and fibronectin deposition.

Limitations

The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.

Digital Object Identifier (DOI)

10.1371/journal.pone.0015893

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication